Diseases, Conditions, Syndromes

Pfizer seeks EU vaccine approval as OECD sees recovery in 2021

Pharma companies Pfizer and BioNTech on Tuesday filed for European approval for their coronavirus vaccine, following in the footsteps of competitor Moderna, while the OECD predicted the world economy would bounce back to ...

Diseases, Conditions, Syndromes

RAS inhibitors not linked to increased risk of death from COVID-19

Concerns have been raised that the use of a common group of medications called RAS inhibitors could facilitate SARS-CoV-2 infection, impact COVID-19 disease severity and worsen prognosis. However, in a new nationwide registry-based ...

Immunology

Boosting stem cell activity can enhance immunotherapy benefits

Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active "super immune cells" with strong antitumor activity, according to new research from Georgetown ...

Diseases, Conditions, Syndromes

A sulfur molecule to block the coronavirus

The cell membrane is impermeable to viruses—to get inside and infect a cell, they use a range of strategies to exploit the cellular and biochemical properties of the membranes. The thiol-mediated uptake of organic molecules ...

Vaccination

Pfizer/BioNTech file for emergency approval for virus vaccine

Pfizer confirmed Friday and that it and partner BioNTech have applied for emergency use authorization for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.

Diseases, Conditions, Syndromes

How rotavirus causes severe gastrointestinal disease

Rotavirus is a major cause of diarrhea and vomiting, especially in children, that results in approximately 128,000 deaths annually. The virus triggers the disease by infecting enterocyte cells in the small intestine, but ...

Oncology & Cancer

Scientists discover roles for a cellular motor in cancer

Utah scientists have discovered new functions of a key cellular machine that regulates gene packaging and is mutated in 20% of human cancers. The study was published in print today in the journal Molecular Cell.

page 1 from 40